Inter Pharma Public Company Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was THB 402.31 million compared to THB 240.38 million a year ago. Revenue was THB 403.49 million compared to THB 244.39 million a year ago. Net income was THB 30.45 million compared to THB 24.38 million a year ago. Basic earnings per share from continuing operations was THB 0.09 compared to THB 0.08 a year ago.
For the nine months, sales was THB 1,082.22 million compared to THB 615.18 million a year ago. Revenue was THB 1,087.97 million compared to THB 623.54 million a year ago. Net income was THB 91.02 million compared to THB 65.16 million a year ago. Basic earnings per share from continuing operations was THB 0.29 compared to THB 0.22 a year ago.